Igor Beletsky
6Patents
4h-index
4Co-inventors
50Inventor score
Filing activity: Jun 7, 1995 → Apr 9, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6262239A | TNF receptor-specific antibodies | Chemistry; Metallurgy | 16 | Expired |
| US6232446A | TNF ligands | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6555111B2 | Method of inhibiting the cytocidal effect of TNF with TNF receptor-specific antibodies | Chemistry; Metallurgy | 12 | Expired |
| US6602993B2 | DNA molecule encoding TNF binding ligands and vectors and host cells containing the DNA molecule | Emerging Cross-Sectional Technologies | 5 | Expired |
| US12359171B2 | Method for producing NK cells with PD-1 knockout gene and trail or FAS-ligand overexpression | Chemistry; Metallurgy | 0 | Active |
| US7455977B2 | Methods of determining the level of human TBP-II with anti-TBP-II antibody | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.